BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//FQHC Talent//The Record//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:FQHC Talent — 340B drug pricing
REFRESH-INTERVAL;VALUE=DURATION:PT24H
X-PUBLISHED-TTL:PT24H
BEGIN:VEVENT
UID:intel:amgen-340b-visit-claims-data-request-november-15-2026@fqhctalent.
 com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261115
DTEND;VALUE=DATE:20261116
SUMMARY:Amgen to request 340B visit claims data starting November 15
DESCRIPTION:Amgen to request 340B visit claims data starting November 15\n\
 nhttps://www.amgen.com/newsroom/company-statements/340b-program-integrity-
 policy-update
URL:https://www.amgen.com/newsroom/company-statements/340b-program-integrit
 y-policy-update
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:aha-v-kennedy-court-sets-november-18-hearing-340b-rebate-pilot-no
 vember-2026@fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261118
DTEND;VALUE=DATE:20261119
SUMMARY:Hearing in Maine on the hospitals' motion to block the 340B rebate 
 pilot
DESCRIPTION:Hearing in Maine on the hospitals' motion to block the 340B reb
 ate pilot\n\nhttps://www.courtlistener.com/docket/74942409/american-hospit
 al-association-v-kennedy/
URL:https://www.courtlistener.com/docket/74942409/american-hospital-associa
 tion-v-kennedy/
CATEGORIES:HEARING
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-part-d-pharmacy-contracting-standards-rfi-340b-sept-2026@fqhc
 talent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261123
DTEND;VALUE=DATE:20261124
SUMMARY:Comments are due on CMS's request for input on Part D pharmacy cont
 ract terms\, including 340B claims
DESCRIPTION:Comments are due on CMS's request for input on Part D pharmacy 
 contract terms\, including 340B claims\n\nhttps://www.federalregister.gov/
 documents/2026/09/24/2026-19535/request-for-information-medicare-part-d-re
 asonable-and-relevant-pharmacy-contracting-standards
URL:https://www.federalregister.gov/documents/2026/09/24/2026-19535/request
 -for-information-medicare-part-d-reasonable-and-relevant-pharmacy-contract
 ing-standards
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:state-intel:ms-cd72f4943d9c@fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261127
DTEND;VALUE=DATE:20261128
SUMMARY:Mississippi's response to Novartis's Supreme Court petition on its 
 340B law is due
DESCRIPTION:Mississippi's response to Novartis's Supreme Court petition on 
 its 340B law is due\n\nhttps://www.supremecourt.gov/search.aspx?filename=/
 docket/docketfiles/html/public/26-457.html
URL:https://www.supremecourt.gov/search.aspx?filename=/docket/docketfiles/h
 tml/public/26-457.html
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-globe-model-final-rule-340b-units-excluded-october-2026@fqhct
 alent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261130
DTEND;VALUE=DATE:20261201
SUMMARY:CMS's GLOBE Medicare Part B drug rebate model takes effect and leav
 es out 340B claims
DESCRIPTION:CMS's GLOBE Medicare Part B drug rebate model takes effect and 
 leaves out 340B claims\n\nhttps://www.federalregister.gov/documents/2026/1
 0/02/2026-20281/global-benchmark-for-efficient-drug-pricing-globe-model
URL:https://www.federalregister.gov/documents/2026/10/02/2026-20281/global-
 benchmark-for-efficient-drug-pricing-globe-model
CATEGORIES:EFFECTIVE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:advocacy:wa-340b-manufacturer-lawsuit-novartis-abbvie-2026@fqhctalent.c
 om
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:Ninth Circuit argument on the drugmakers' appeal against Washington
 's 340B contract-pharmacy law
DESCRIPTION:Ninth Circuit argument on the drugmakers' appeal against Washin
 gton's 340B contract-pharmacy law\n\nhttps://www.courtlistener.com/docket/
 73487650/abbvie-inc-et-al-v-brown-et-al/
URL:https://www.courtlistener.com/docket/73487650/abbvie-inc-et-al-v-brown-
 et-al/
CATEGORIES:HEARING
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-4214-p-medicare-pbm-340b-reporting-proposed-rule-october-2026
 @fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261215
DTEND;VALUE=DATE:20261216
SUMMARY:CMS proposes Medicare rule making pharmacy benefit managers report 
 340B arrangements
DESCRIPTION:CMS proposes Medicare rule making pharmacy benefit managers rep
 ort 340B arrangements\n\nhttps://www.govinfo.gov/content/pkg/FR-2026-10-20
 /html/2026-21420.htm
URL:https://www.govinfo.gov/content/pkg/FR-2026-10-20/html/2026-21420.htm
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:intel:cms-medicare-part-d-340b-claims-repository-live-october-2026@fqhc
 talent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20261231
DTEND;VALUE=DATE:20270101
SUMMARY:Planned due date for voluntary Part D 340B claims submissions cover
 ing January 1 to September 30\, 2026
DESCRIPTION:Planned due date for voluntary Part D 340B claims submissions c
 overing January 1 to September 30\, 2026\n\nhttps://www.cms.gov/initiative
 s/medicare-prescription-drug-affordability/overview/medicare-inflation-reb
 ate-program
URL:https://www.cms.gov/initiatives/medicare-prescription-drug-affordabilit
 y/overview/medicare-inflation-rebate-program
CATEGORIES:DEADLINE
STATUS:TENTATIVE
END:VEVENT
BEGIN:VEVENT
UID:intel:hrsa-approves-ten-manufacturer-340b-rebate-plans-october-2026@fqh
 ctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20270101
DTEND;VALUE=DATE:20270102
SUMMARY:Rebates start under the 340B rebate plans HRSA approved for ten dru
 gmakers
DESCRIPTION:Rebates start under the 340B rebate plans HRSA approved for ten
  drugmakers\n\nhttps://www.hrsa.gov/opa/340b-model-pilot-program
URL:https://www.hrsa.gov/opa/340b-model-pilot-program
CATEGORIES:EFFECTIVE
STATUS:CONFIRMED
END:VEVENT
BEGIN:VEVENT
UID:compliance:cms-part-d-340b-claims-reporting-2027@fqhctalent.com
DTSTAMP:20261111T000000Z
DTSTART;VALUE=DATE:20270930
DTEND;VALUE=DATE:20271001
SUMMARY:Medicare Part D 340B claims: first mandatory report due
DESCRIPTION:Medicare Part D 340B claims: first mandatory report due\n\nhttp
 s://www.federalregister.gov/documents/2026/11/09/2026-22743/medicare-and-m
 edicaid-programs-cy-2027-payment-policies-under-the-physician-fee-schedule
 -and-other
URL:https://www.federalregister.gov/documents/2026/11/09/2026-22743/medicar
 e-and-medicaid-programs-cy-2027-payment-policies-under-the-physician-fee-s
 chedule-and-other
CATEGORIES:DEADLINE
STATUS:CONFIRMED
END:VEVENT
END:VCALENDAR
